Trials / Completed
CompletedNCT01601327
Effects of Medications in Patients With Hypogonadism
Effects of Three Different Medications on Metabolic Parameters and Testicular Volume in Patients With Hypogonadotropic Hypogonadism-Last Three Years Experience
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 119 (actual)
- Sponsor
- Gulhane School of Medicine · Academic / Other
- Sex
- Male
- Age
- 18 Years – 30 Years
- Healthy volunteers
- Accepted
Summary
The aim of the present study was to demonstrate the influences of three different treatment strategies on biochemical parameters and testicular volume (TV) in patients with idiopathic hypogonadotropic hypogonadism (IHH).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Testosterone enanthate (Sustanon 250 mg) | Twenty-eight patients were treated with testosterone enanthate (TE), |
| DRUG | Human chorionic gonadotropin (hCG) (Pregnyl 5000 IU) | twenty-five patients were treated with human chorionic gonadotropin (hCG) |
| DRUG | Testosteron gel (Testojel 50 mg) | Twenty-four patients were treated with testosterone gel (TG). |
Timeline
- Start date
- 2008-01-01
- Primary completion
- 2012-03-01
- Completion
- 2012-03-01
- First posted
- 2012-05-18
- Last updated
- 2012-05-18
Locations
2 sites across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT01601327. Inclusion in this directory is not an endorsement.